Aspergillus sensitization in bronchial asthma: A separate phenotype

Area of Science:

• Respiratory Medicine
• Allergology
• Clinical Immunology

Background:

• Bronchial asthma affects 300 million globally, with India bearing a significant burden.
• Airway hyperresponsiveness in asthma can be triggered by endogenous stimuli like fungal antigens.
• Aspergillus sensitization is implicated in asthma pathogenesis, potentially leading to severe asthma with fungal sensitivity.

Purpose of the Study:

• To evaluate Aspergillus sensitization in bronchial asthma patients.
• To assess the impact of Aspergillus sensitization on asthma control.
• To explore the association between fungal sensitization and asthma severity.

Main Methods:

• Prospective enrollment of 57 bronchial asthma patients.
• Evaluation of Aspergillus sensitization.
• Assessment of asthma control using symptom control metrics.

Main Results:

• A higher proportion of sensitized patients experienced uncontrolled asthma symptoms (45.00%) compared to non-sensitized patients (18.92%).
• Well-controlled symptoms were more prevalent in non-sensitized individuals (62.16%) than in sensitized ones (50.00%).
• Aspergillus sensitization was significantly associated with bronchiectasis, irrespective of clinical presentation.

Conclusions:

• Fungal sensitization, specifically to Aspergillus, is associated with increased asthma severity.
• Aspergillus sensitization plays a role in the pathogenesis of asthma.
• Identifying Aspergillus sensitization is crucial for managing asthma and may indicate underlying bronchiectasis.